Primary Immunodeficiency Diseases
4 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.
Broader: Immune System Diseases, Immunologic Deficiency Syndromes
Narrower: X-Linked Combined Immunodeficiency Diseases 2
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Base-edited hematopoietic stem and progenitor cells + ALEMTUZUMAB + Busulfan + FILGRASTIM + PALIFERMIN + PLERIXAFOR for x-linked combined immunodeficiency diseases | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Direct intravenous injection of ivlv-X1 lentiviral vector for x-linked combined immunodeficiency diseases | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Haploidentical Hematopoietic Cell Transplantation for primary immunodeficiency diseases | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Rivogenlecleucel + rimiducid for primary immunodeficiency diseases | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.